3,4-dihydroxyphenylacetic acid has been researched along with Cancer of Liver in 1 studies
3,4-Dihydroxyphenylacetic Acid: A deaminated metabolite of LEVODOPA.
(3,4-dihydroxyphenyl)acetic acid : A dihydroxyphenylacetic acid having the two hydroxy substituents located at the 3- and 4-positions. It is a metabolite of dopamine.
dihydroxyphenylacetic acid : A dihydroxy monocarboxylic acid consisting of phenylacetic acid having two phenolic hydroxy substituents.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, Y | 1 |
| Kurita, A | 1 |
| Nakashima, S | 1 |
| Zhu, B | 1 |
| Munemasa, S | 1 |
| Nakamura, T | 1 |
| Murata, Y | 1 |
| Nakamura, Y | 1 |
1 other study available for 3,4-dihydroxyphenylacetic acid and Cancer of Liver
| Article | Year |
|---|---|
3,4-Dihydroxyphenylacetic acid is a potential aldehyde dehydrogenase inducer in murine hepatoma Hepa1c1c7 cells.
Topics: 3,4-Dihydroxyphenylacetic Acid; Acetaldehyde; Aldehyde Dehydrogenase; Animals; Carcinoma, Hepatocell | 2017 |